George R. Painter

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “4′-Fluorouridine inhibits alphavirus replication and infection in vitro and in vivo”.

4′-Fluorouridine inhibits alphavirus replication and infection in vitro and in vivo

mBio(2024)10.1128/mbio.00420-24

N/A

0.520DataRank · unranked

31 citations

Nicholas May, Laura Sandra Lello, Atef Fayed, M. Guston Parks, Adam M. Drobish +10 more

Modeling Heartland virus disease in mice and therapeutic intervention with 4′-fluorouridine

Journal of Virology(2024)10.1128/jvi.00132-24

N/A

0.494DataRank · unranked

13 citations

Kie Hoon Jung, Cigdem Alkan, Kirsten M. Boardman, Arnaud J. Van Wettere, Craig Martens +13 more

Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab305

N/A

0DataRank · unranked

41 citations

James M. Anderson, Annaliesa S. Anderson, David Baker, Jay Bradner, Kyle R. Brimacombe +37 more

4’-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replication

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.19.444875

N/A

0DataRank · unranked

6 citations

Carolin M. Lieber, Megha Aggarwal, Robert M. Cox, Josef D. Wolf, Jeong-Joong Yoon +10 more

SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model

Nature Communications(2022)10.1038/s41467-022-32045-1

N/A

0DataRank · unranked

51 citations

Robert M. Cox, Julien Sourimant, Josef D. Wolf, Kate B. Juergens, Quynh Phung +10 more

The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection

Antiviral Research(2022)10.1016/j.antiviral.2022.105453

N/A

0DataRank · unranked

17 citations

Shuli Mao, Michael G. Natchus, Wendy Painter, Sabue Mulangu, Mark A. Lockwood +7 more

SARS-CoV-2 variant of concern type and biological sex affect efficacy of molnupiravir in dwarf hamster model of severe COVID-19

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.04.479171

N/A

0DataRank · unranked

9 citations

Robert M. Cox, Julien Sourimant, Josef D. Wolf, Kate B. Juergens, Quynh Phung +7 more

Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferrets

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.20.517271

N/A

0DataRank · unranked

5 citations

Carolin M. Lieber, Josef D. Wolf, Amir-Hossein Karimi, Nicole A. P. Lieberman, Zachary M. Sticher +9 more

The Prophylactic and Therapeutic Efficacy of the Broadly Active Antiviral Ribonucleoside N 4 -Hydroxycytidine (EIDD-1931) in a Mouse Model of Lethal Ebola Virus Infection

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.18.512767

N/A

0DataRank · unranked

0 citations

Shuli Mao, Michael G. Natchus, Wendy Painter, Sabue Mulangu, Mark A. Lockwood +7 more

4’-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses

PLoS Pathogens(2023)10.1371/journal.ppat.1011342

N/A

0DataRank · unranked

44 citations

Megha Aggarwal, Jeong-Joong Yoon, Robert M. Cox, Hae-Ji Kang, Julien Sourimant +13 more

Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models

Nature Communications(2023)10.1038/s41467-023-40556-8

N/A

0DataRank · unranked

35 citations

Carolin M. Lieber, Josef D. Wolf, Amir-Hossein Karimi, Nicole A. P. Lieberman, Zachary M. Sticher +9 more

Delayed low-dose oral administration of 4′-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal disease

Science Translational Medicine(2024)10.1126/scitranslmed.ado7034

N/A

0DataRank · unranked

30 citations

Jessica R. Spengler, Jonna B. Westover, Kevin W. Bailey, Katherine Davies, Virginia Aida-Ficken +30 more

Oral 4′-fluorouridine rescues mice from advanced lymphocytic choriomeningitis virus infection

Antiviral Research(2025)10.1016/j.antiviral.2025.106122

N/A

0DataRank · unranked

4 citations

Kie Hoon Jung, Shuli Mao, Alexander A. Kolykhalov, Gregory R. Bluemling, Michael G. Natchus +3 more

Pathogenesis of Hazara orthonairovirus infection in type I interferon receptor-deficient mice and resolution of disease following 4′-fluorouridine therapy

Journal of Virology(2025)10.1128/jvi.01421-25

N/A

0DataRank · unranked

1 citations

Jonna B. Westover, Dionna Scharton, Arnaud J. Van Wettere, Alexander A. Kolykhalov, Shuli Mao +4 more

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.19.997890

N/A

0DataRank · unranked

34 citations

Amy Sims, Shuntai Zhou, Rachel L. Graham, Collin S Hill, Sarah R. Leist +19 more

Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.21.695822

N/A

0DataRank · unranked

0 citations

Josef D. Wolf, Mugunthan Govindarajan, Jeong_Joong Yoon, Zachary M. Sticher, Claire Ruckel +12 more

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

Nature(2021)10.1038/s41586-021-03312-w

N/A

0DataRank · unranked

432 citations

Lisa E. Gralinski, Claire Johnson, Wenbo Yao, Martina Kovářová, Kenneth H. Dinnon +21 more